Beauty Health Company (SKIN) has disclosed a new risk, in the Debt & Financing category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The restrictive covenants embedded within the 2028 Notes of Beauty Health Company could significantly constrain its operational flexibility. These covenants limit the company’s ability to engage in debt financing, asset transactions, and various strategic initiatives, including mergers and acquisitions. Such restrictions may hinder the company’s capacity to adapt to industry changes or pursue growth opportunities. Additionally, non-compliance with these covenants could trigger a default event, posing a substantial risk to the company’s financial stability.
Overall, Wall Street has a Hold consensus rating on SKIN stock based on 1 Sell and 4 Holds.
To learn more about Beauty Health Company’s risk factors, click here.